Atlas Trials

Safety and Efficacy of Maraviroc and/or Favipiravir With Standard Therapy in Severe COVID-19 Adults

Clinical trial NCT04475991 · TERMINATED

Trial details

NCT number
NCT04475991
Sponsor
Hospital General de México Dr. Eduardo Liceaga
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2021-07-13
Primary completion
2022-03-15
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.